EMA Discusses Disruptive Impact Of ‘Bad Submission Planning’ By Pharma

 
• By Vibha Sharma
  
Businessman with aspiration of becoming superhero
Companies Should Avoid Being Overly Optimistic When Deciding On Their Planned Filing Date (Shutterstock)

More from Pathways & Standards

More from Agency Leadership